Advertisement

Alström Syndrome: What You Need To Know For Diagnosis & Care

Understanding Alström Syndrome: A rare genetic condition linking diabetes, vision loss, hearing impairment, and multi-organ challenges.

By Medha deb
Created on

Alström Syndrome is a rare genetic disorder affecting multiple organ systems, primarily characterized by progressive vision and hearing loss, childhood obesity, insulin resistance leading to type 2 diabetes, dilated cardiomyopathy, and progressive kidney dysfunction.

What is Alström Syndrome?

Alström Syndrome is a complex, monogenic disorder caused by mutations in the ALMS1 gene, inherited in an autosomal recessive manner. This means both parents must carry the mutated gene for a child to be affected. The condition impacts vision, hearing, metabolism, heart, liver, kidneys, and lungs, often presenting in infancy or early childhood. Unlike many genetic syndromes, intelligence is typically preserved, though developmental delays in motor skills may occur.

The syndrome was first described in 1957 by Swedish endocrinologist Carl-Henry Alström. It affects approximately 1 in 1 million people worldwide, with fewer than 1,000 cases reported globally. Early symptoms like vision loss mimic other retinal dystrophies, but the multisystem involvement distinguishes it.

Symptoms of Alström Syndrome

Symptoms vary in onset and severity but follow a progressive pattern. Key features include:

  • Vision loss: Progressive retinal dystrophy leads to photophobia (light sensitivity) in infancy, followed by nystagmus (eye shaking) and legal blindness by adolescence. Central vision is most affected.
  • Hearing impairment: Sensorineural hearing loss typically begins in childhood, progressing to profound deafness by adulthood. Early hearing aids or cochlear implants can help.
  • Obesity: Rapid weight gain starts in early childhood due to lower energy requirements, reduced activity from sensory losses, and metabolic changes. This increases risks for related complications.
  • Type 2 diabetes and insulin resistance: Hyperinsulinemia develops in childhood, progressing to type 2 diabetes by adolescence or early adulthood (sometimes as young as 4-5 years). Symptoms include polyuria, polydipsia, and hyperglycemia.
  • Cardiomyopathy: Dilated cardiomyopathy causes heart failure in infancy (often improving temporarily), recurring in adulthood. Monitoring via echocardiograms is essential.
  • Kidney dysfunction: Progressive renal failure, either acute or chronic, often linked to diabetes or glomerular issues. Proteinuria and elevated creatinine signal progression.
  • Liver and lung issues: Fatty liver disease, fibrosis, or cirrhosis; pulmonary hypertension or fibrosis may cause respiratory distress.
  • Other features: Acanthosis nigricans (dark skin patches indicating insulin resistance), hypertriglyceridemia (risking pancreatitis), hypothyroidism, short stature, and genital abnormalities in males.

Table summarizing common symptoms by age:

Age GroupCommon Symptoms
Infancy (0-2 years)Vision loss, cardiomyopathy, failure to thrive
Childhood (3-12 years)Hearing loss, obesity, insulin resistance
Adolescence/AdulthoodType 2 diabetes, renal failure, recurrent heart issues, liver dysfunction

Causes of Alström Syndrome

Alström Syndrome results from biallelic mutations in the ALMS1 gene on chromosome 2p13.1. This gene encodes a protein involved in ciliary function, intracellular trafficking, and centrosome cohesion, affecting cell signaling and organ development. Over 200 mutations have been identified, leading to truncated or dysfunctional ALMS1 protein.

As an autosomal recessive disorder, carriers (parents) show no symptoms. Consanguinity increases risk. Genetic testing confirms diagnosis via sequencing of ALMS1, revealing homozygous or compound heterozygous variants.

Diagnosis

Diagnosis combines clinical features, family history, and genetic confirmation. No single test suffices due to phenotypic overlap with Bardet-Biedl or Usher syndromes.

  • Clinical evaluation: Ophthalmologic (retinal dystrophy), audiologic (hearing loss), metabolic (insulin resistance, hyperlipidemia), cardiac (echocardiogram), and renal (GFR assessment) tests.
  • Genetic testing: Next-generation sequencing identifies ALMS1 mutations, essential for definitive diagnosis.
  • Differential diagnosis: Rule out Bardet-Biedl (polydactyly), Cohen syndrome (microcephaly), or Wolfram syndrome (diabetes insipidus).

Early diagnosis via newborn screening for cardiomyopathy or genetic panels for retinal dystrophies aids timely intervention.

Treatment and management

No cure exists; management is symptomatic and multidisciplinary, involving endocrinologists, ophthalmologists, audiologists, cardiologists, nephrologists, and genetic counselors.

  • Diabetes/insulin resistance: Metformin or thiazolidinediones (insulin sensitizers) first-line; high-dose insulin if needed (>1 unit/kg/day). Diet low in refined carbs, calories; monitor HbA1c.
  • Obesity: Calorie-controlled diet, physical therapy for safe exercise despite vision/hearing loss.
  • Cardiac: ACE inhibitors, beta-blockers, diuretics for heart failure; transplant in end-stage.
  • Vision/hearing: Sunglasses, low-vision aids; hearing aids/cochlear implants.
  • Renal/liver: ACE inhibitors for proteinuria; dialysis/transplant for failure; ursodeoxycholic acid for liver issues.
  • Lipids: Statins/fibrates for hypertriglyceridemia to prevent pancreatitis.

Regular monitoring: Annual blood tests (glucose, lipids, liver/kidney function), echocardiograms, eye/ear exams.

Living with Alström Syndrome

Patients face sensory losses, metabolic challenges, and organ failure risks, impacting quality of life. Support includes:

  • Multidisciplinary care: Coordinated via rare disease centers.
  • Lifestyle: Adapted physical activity, balanced nutrition.
  • Psychosocial support: Counseling for sensory loss, independence training.
  • Prognosis: Reduced lifespan (median ~50 years) due to cardiac/renal failure, but early management improves outcomes.

Support and resources

Alström Syndrome International (ASI) provides family support, research updates, and events. In the UK, contact Diabetes UK or genetic services. Genetic counseling is crucial for families planning pregnancies.

Frequently asked questions

Is Alström Syndrome curable?

No, but multidisciplinary management controls symptoms and delays complications.

Can children with Alström Syndrome attend mainstream school?

Yes, with vision/hearing aids and support, as intelligence is normal.

Does everyone with Alström Syndrome get diabetes?

Nearly all develop insulin-resistant type 2 diabetes by young adulthood.

How is Alström Syndrome inherited?

Autosomal recessive; 25% risk per pregnancy if both parents are carriers.

What is the role of genetic testing?

Confirms diagnosis and enables family screening.

References

  1. Alström Syndrome – Symptoms, Causes, Treatment — NORD (National Organization for Rare Disorders). 2023. https://rarediseases.org/rare-diseases/alstrom-syndrome/
  2. Alström Syndrome — Diabetes UK. 2024. https://www.diabetes.org.uk/about-diabetes/other-types-of-diabetes/alstrom-syndrome
  3. Alström Syndrome: A Rare Cause of Severe Insulin Resistance — PMC/NCBI (Peer-reviewed). 2023-10-15. https://pmc.ncbi.nlm.nih.gov/articles/PMC10578372/
  4. What is Alström Syndrome — Alström Syndrome International. 2024. https://www.alstrom.org/what-is-alstrom-syndrome
  5. Alström Syndrome — MedlinePlus Genetics (U.S. National Library of Medicine). 2024. https://medlineplus.gov/genetics/condition/alstrom-syndrome/
Medha Deb is an editor with a master's degree in Applied Linguistics from the University of Hyderabad. She believes that her qualification has helped her develop a deep understanding of language and its application in various contexts.

Read full bio of medha deb